Skip to main content

Artificial Intelligence for Medical and Pharmaceutical Research: Can Artificial Intelligence Help in the Discovery and Development of New Drugs?

  • Chapter
  • First Online:
Healthcare and Artificial Intelligence
  • 1128 Accesses

Abstract

The digitalization of biology and medicine is producing an exponential amount of data. Combined with the emergence of new analytical AI tools, unprecedented opportunities to accelerate medical progress are emerging. Today, two major areas are about to undergo a profound transformation: medical and pharmaceutical research as well as clinical practice from diagnosis to therapeutic management. Can AI help in the discovery and development of better drugs?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 37.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    Krizhevsky A., Sutskever I., Hinton G.E., “Imagenet classification with deep convolutional neural networks,” Advances in Neural Information Processing Systems, 2012, 1097–1105.

  2. 2.

    Serendipity is the act of making a scientific discovery or technological invention unexpectedly as a result of a combination of chance circumstances and very often in the context of research on another subject.

  3. 3.

    Courtiol, P., Maussion, C., Moarii, M. et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med 25, 1519–1525 (2019). https://doi.org/10.1038/s41591-019-0583-3

  4. 4.

    Mobadersany P., Yousefi S., Amgad M., Gutman D.A., Barnholtz-Sloan J.S., Vega J.E.V., Cooper L.A., “Predicting cancer outcomes from histology and genomics using convolutional networks,” Proceedings of the National Academy of Sciences, 2018, 201717139.

  5. 5.

    Absorption, distribution, metabolism, excretion.

  6. 6.

    https://www.ft.com/content/ef7be832-86d0-11e9-a028-86cea8523dc2

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilles Wainrib .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wainrib, G. (2020). Artificial Intelligence for Medical and Pharmaceutical Research: Can Artificial Intelligence Help in the Discovery and Development of New Drugs?. In: Nordlinger, B., Villani, C., Rus, D. (eds) Healthcare and Artificial Intelligence. Springer, Cham. https://doi.org/10.1007/978-3-030-32161-1_26

Download citation

Publish with us

Policies and ethics